Use of ketorolac in sickle-cell disease and vaso-occlusive crisis
- PMID: 1679183
- DOI: 10.1016/0140-6736(91)90656-a
Use of ketorolac in sickle-cell disease and vaso-occlusive crisis
Similar articles
-
Effect of ketorolac in pediatric sickle cell vaso-occlusive pain crisis.Pediatr Emerg Care. 1999 Jun;15(3):179-82. doi: 10.1097/00006565-199906000-00004. Pediatr Emerg Care. 1999. PMID: 10389953 Clinical Trial.
-
Sickle cell vaso-occlusive pain crisis in adults: alternative strategies for management in the emergency department.South Med J. 1992 Aug;85(8):808-11. doi: 10.1097/00007611-199208000-00005. South Med J. 1992. PMID: 1302470
-
Meperidine and ketorolac in the treatment of painful sickle cell crisis.Ann Emerg Med. 1993 Oct;22(10):1639-40. doi: 10.1016/s0196-0644(05)81279-x. Ann Emerg Med. 1993. PMID: 8214851 No abstract available.
-
Ketorolac: an alternative for the management of acute pain.MCN Am J Matern Child Nurs. 1997 Jan-Feb;22(1):56. doi: 10.1097/00005721-199701000-00018. MCN Am J Matern Child Nurs. 1997. PMID: 9002691 Review. No abstract available.
-
Ketorolac (Toradol) for dental pain.Gen Dent. 1992 Nov-Dec;40(6):476-9. Gen Dent. 1992. PMID: 1298670 Review. No abstract available.
Cited by
-
State of the Art Management of Acute Vaso-occlusive Pain in Sickle Cell Disease.Paediatr Drugs. 2018 Feb;20(1):29-42. doi: 10.1007/s40272-017-0263-z. Paediatr Drugs. 2018. PMID: 28853040 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical